Biliary Tract Cancers, Version 2.2023 Featured Updates to the NCCN Guidelines

Al B. Benson; Michael I. D’Angelica; Thomas Abrams; Daniel E. Abbott; Aijaz Ahmed; Daniel A. Anaya; Robert Anders; Chandrakanth Are; Melinda Bachini; David Binder; Mitesh Borad; Christopher Bowlus; Daniel Brown; Adam Burgoyne; Jason Castellanos; Prabhleen Chahal; Jordan Cloyd; Anne M. Covey; Evan S. Glazer; William G. Hawkins; Renuka Iyer; Rojymon Jacob; Lawrence Jennings; R. Kate Kelley; Robin Kim; Matthew Levine; Manisha Palta; James O. Park; Steven Raman; Sanjay Reddy; Sean Ronnekleiv-Kelly; Vaibhav Sahai; Gagandeep Singh; Stacey Stein; Anita Turk; Jean Nicolas Vauthey; Alan P. Venook; Adam Yopp; Nicole McMillian; Ryan Schonfeld; Cindy Hochstetler

doi:10.6004/jnccn.2023.0035

Biliary Tract Cancers, Version 2.2023 Featured Updates to the NCCN Guidelines

Al B. Benson, Michael I. D’Angelica, Thomas Abrams, Daniel E. Abbott, Aijaz Ahmed, Daniel A. Anaya, Robert Anders, Chandrakanth Are, Melinda Bachini, David Binder, Mitesh Borad, Christopher Bowlus, Daniel Brown, Adam Burgoyne, Jason Castellanos, Prabhleen Chahal, Jordan Cloyd, Anne M. Covey, Evan S. Glazer, William G. HawkinsRenuka Iyer, Rojymon Jacob, Lawrence Jennings, R. Kate Kelley, Robin Kim, Matthew Levine, Manisha Palta, James O. Park, Steven Raman, Sanjay Reddy, Sean Ronnekleiv-Kelly, Vaibhav Sahai, Gagandeep Singh, Stacey Stein, Anita Turk, Jean Nicolas Vauthey, Alan P. Venook, Adam Yopp, Nicole McMillian, Ryan Schonfeld, Cindy Hochstetler

Surgical Oncology

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Abstract

In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate guidelines: Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for Biliary Tract Cancers provide recommendations for the evaluation and comprehensive care of patients with gallbladder cancer, intrahepatic cholangiocarcinoma, and extrahepatic cholangiocarcinoma. The multidisciplinary panel of experts meets at least on an annual basis to review requests from internal and external entities as well as to evaluate new data on current and emerging therapies. These Guidelines Insights focus on some of the recent updates to the NCCN Guidelines for Biliary Tract Cancers as well as the newly published section on principles of molecular testing.

Original language	English (US)
Pages (from-to)	694-704
Number of pages	11
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	21
Issue number	7
DOIs	https://doi.org/10.6004/jnccn.2023.0035
State	Published - Jul 2023

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2023.0035

Cite this

Benson, A. B., D’Angelica, M. I., Abrams, T., Abbott, D. E., Ahmed, A., Anaya, D. A., Anders, R., Are, C., Bachini, M., Binder, D., Borad, M., Bowlus, C., Brown, D., Burgoyne, A., Castellanos, J., Chahal, P., Cloyd, J., Covey, A. M., Glazer, E. S., ... Hochstetler, C. (2023). Biliary Tract Cancers, Version 2.2023 Featured Updates to the NCCN Guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 21(7), 694-704. https://doi.org/10.6004/jnccn.2023.0035

Benson, AB, D’Angelica, MI, Abrams, T, Abbott, DE, Ahmed, A, Anaya, DA, Anders, R, Are, C, Bachini, M, Binder, D, Borad, M, Bowlus, C, Brown, D, Burgoyne, A, Castellanos, J, Chahal, P, Cloyd, J, Covey, AM, Glazer, ES, Hawkins, WG, Iyer, R, Jacob, R, Jennings, L, Kelley, RK, Kim, R, Levine, M, Palta, M, Park, JO, Raman, S, Reddy, S, Ronnekleiv-Kelly, S, Sahai, V, Singh, G, Stein, S, Turk, A, Vauthey, JN, Venook, AP, Yopp, A, McMillian, N, Schonfeld, R & Hochstetler, C 2023, 'Biliary Tract Cancers, Version 2.2023 Featured Updates to the NCCN Guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 21, no. 7, pp. 694-704. https://doi.org/10.6004/jnccn.2023.0035

@article{4b512883759d40018487eec38b14d513,

title = "Biliary Tract Cancers, Version 2.2023 Featured Updates to the NCCN Guidelines",

abstract = "In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate guidelines: Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for Biliary Tract Cancers provide recommendations for the evaluation and comprehensive care of patients with gallbladder cancer, intrahepatic cholangiocarcinoma, and extrahepatic cholangiocarcinoma. The multidisciplinary panel of experts meets at least on an annual basis to review requests from internal and external entities as well as to evaluate new data on current and emerging therapies. These Guidelines Insights focus on some of the recent updates to the NCCN Guidelines for Biliary Tract Cancers as well as the newly published section on principles of molecular testing.",

author = "Benson, {Al B.} and D{\textquoteright}Angelica, {Michael I.} and Thomas Abrams and Abbott, {Daniel E.} and Aijaz Ahmed and Anaya, {Daniel A.} and Robert Anders and Chandrakanth Are and Melinda Bachini and David Binder and Mitesh Borad and Christopher Bowlus and Daniel Brown and Adam Burgoyne and Jason Castellanos and Prabhleen Chahal and Jordan Cloyd and Covey, {Anne M.} and Glazer, {Evan S.} and Hawkins, {William G.} and Renuka Iyer and Rojymon Jacob and Lawrence Jennings and Kelley, {R. Kate} and Robin Kim and Matthew Levine and Manisha Palta and Park, {James O.} and Steven Raman and Sanjay Reddy and Sean Ronnekleiv-Kelly and Vaibhav Sahai and Gagandeep Singh and Stacey Stein and Anita Turk and Vauthey, {Jean Nicolas} and Venook, {Alan P.} and Adam Yopp and Nicole McMillian and Ryan Schonfeld and Cindy Hochstetler",

year = "2023",

month = jul,

doi = "10.6004/jnccn.2023.0035",

language = "English (US)",

volume = "21",

pages = "694--704",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "7",

}

TY - JOUR

T1 - Biliary Tract Cancers, Version 2.2023 Featured Updates to the NCCN Guidelines

AU - Benson, Al B.

AU - D’Angelica, Michael I.

AU - Abrams, Thomas

AU - Abbott, Daniel E.

AU - Ahmed, Aijaz

AU - Anaya, Daniel A.

AU - Anders, Robert

AU - Are, Chandrakanth

AU - Bachini, Melinda

AU - Binder, David

AU - Borad, Mitesh

AU - Bowlus, Christopher

AU - Brown, Daniel

AU - Burgoyne, Adam

AU - Castellanos, Jason

AU - Chahal, Prabhleen

AU - Cloyd, Jordan

AU - Covey, Anne M.

AU - Glazer, Evan S.

AU - Hawkins, William G.

AU - Iyer, Renuka

AU - Jacob, Rojymon

AU - Jennings, Lawrence

AU - Kelley, R. Kate

AU - Kim, Robin

AU - Levine, Matthew

AU - Palta, Manisha

AU - Park, James O.

AU - Raman, Steven

AU - Reddy, Sanjay

AU - Ronnekleiv-Kelly, Sean

AU - Sahai, Vaibhav

AU - Singh, Gagandeep

AU - Stein, Stacey

AU - Turk, Anita

AU - Vauthey, Jean Nicolas

AU - Venook, Alan P.

AU - Yopp, Adam

AU - McMillian, Nicole

AU - Schonfeld, Ryan

AU - Hochstetler, Cindy

PY - 2023/7

Y1 - 2023/7

N2 - In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate guidelines: Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for Biliary Tract Cancers provide recommendations for the evaluation and comprehensive care of patients with gallbladder cancer, intrahepatic cholangiocarcinoma, and extrahepatic cholangiocarcinoma. The multidisciplinary panel of experts meets at least on an annual basis to review requests from internal and external entities as well as to evaluate new data on current and emerging therapies. These Guidelines Insights focus on some of the recent updates to the NCCN Guidelines for Biliary Tract Cancers as well as the newly published section on principles of molecular testing.

AB - In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate guidelines: Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for Biliary Tract Cancers provide recommendations for the evaluation and comprehensive care of patients with gallbladder cancer, intrahepatic cholangiocarcinoma, and extrahepatic cholangiocarcinoma. The multidisciplinary panel of experts meets at least on an annual basis to review requests from internal and external entities as well as to evaluate new data on current and emerging therapies. These Guidelines Insights focus on some of the recent updates to the NCCN Guidelines for Biliary Tract Cancers as well as the newly published section on principles of molecular testing.

UR - http://www.scopus.com/inward/record.url?scp=85164414368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85164414368&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2023.0035

DO - 10.6004/jnccn.2023.0035

M3 - Article

C2 - 37433432

AN - SCOPUS:85164414368

SN - 1540-1405

VL - 21

SP - 694

EP - 704

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 7

ER -

Biliary Tract Cancers, Version 2.2023 Featured Updates to the NCCN Guidelines

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this